» Authors » J M Lang

J M Lang

Explore the profile of J M Lang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 205
Citations 1375
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Helzer K, Sharifi M, Sperger J, Shi Y, Annala M, Bootsma M, et al.
Ann Oncol . 2023 Jun; 34(9):813-825. PMID: 37330052
Background: The isolation of cell-free DNA (cfDNA) from the bloodstream can be used to detect and analyze somatic alterations in circulating tumor DNA (ctDNA), and multiple cfDNA-targeted sequencing panels are...
2.
Bardia A, Messersmith W, Kio E, Berlin J, Vahdat L, Masters G, et al.
Ann Oncol . 2021 Mar; 32(6):746-756. PMID: 33741442
Background: Sacituzumab govitecan (SG), a trophoblast cell surface antigen-2 (Trop-2)-directed antibody-drug conjugate, has demonstrated antitumor efficacy and acceptable tolerability in a phase I/II multicenter trial (NCT01631552) in patients with advanced...
3.
Lang J, DuCharme E, Ibarra Caballero J, Luna E, Hartman T, Ortiz-Castro M, et al.
Phytopathology . 2017 Jul; 107(11):1312-1321. PMID: 28677478
Bacterial leaf streak of corn (Zea mays) recently reached epidemic levels in three corn-growing states, and has been detected in another six states in the central United States. Xanthomonas vasicola...
4.
Hardham A, Green P, Lang J
Planta . 2013 Dec; 149(2):181-95. PMID: 24306251
In the "regeneration" of a shoot from a leaf of the succulent, Graptopetalum paraguayense E. Walther the first new organs are leaf primordia. The original arrangement of cellulose microfibrils and...
5.
Green P, Lang J
Planta . 2013 Dec; 151(5):413-26. PMID: 24302106
Polarity shifts occur during organogenesis. The histological criterion for polarity is the direction of cell division. The biophysical criterion is the orientation of reinforcing cellulose microfibrils which lie normal to...
6.
Sigsby J, Tejada S, Ray W, Lang J, Duncan J
Environ Sci Technol . 2012 Feb; 21(5):466-75. PMID: 22296134
No abstract available.
7.
Demenais F, Mohamdi H, Chaudru V, Goldstein A, Newton Bishop J, Bishop D, et al.
J Natl Cancer Inst . 2010 Sep; 102(20):1568-83. PMID: 20876876
Background: Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associated with a high risk for melanoma. Penetrance of CDKN2A mutations is modified by pigmentation characteristics, nevus phenotypes, and...
8.
Banting F, Gairns S, Lang J, Ross J
Can Med Assoc J . 2010 Mar; 25(4):393-9. PMID: 20318459
No abstract available.
9.
Rey D, Hoen B, Chavanet P, Schmitt M, Hoizey G, Meyer P, et al.
J Antimicrob Chemother . 2008 Nov; 63(2):380-8. PMID: 19036752
Background: The combination of one non-nucleoside reverse transcriptase inhibitor (NNRTI) with two nucleoside reverse transcriptase inhibitors is a validated first-line antiretroviral (ARV) therapy. The once-daily combination of lamivudine, tenofovirDF and...
10.
Lang J
Med Mal Infect . 2006 Nov; 36 Suppl 2:S206-11. PMID: 17075998
No abstract available.